ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,720.83
0.35%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2625
0.01%
Brent Oil
81.295
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Inovio Pharmaceuticals Inc New (INO)

  7. Inovio Pharmaceuticals Inc New (INO) ニュース

INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:INO
日付受信時刻ニュースソース見出しコード企業名
2024/06/0105 : 48PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2905 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/2305 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1706 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1705 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1406 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 05PR Newswire (US)INOVIO Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/1405 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INOInovio Pharmaceuticals Inc New
2024/05/0121 : 00PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
2024/04/2921 : 00PR Newswire (US)INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
2024/04/2921 : 00PR Newswire (US)INOVIO to Participate in Upcoming Investor Conferences in MayNASDAQ:INOInovio Pharmaceuticals Inc New
2024/04/1607 : 39PR Newswire (US)INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:INOInovio Pharmaceuticals Inc New
2024/03/2707 : 28PR Newswire (US)INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicineNASDAQ:INOInovio Pharmaceuticals Inc New
 Showing the most relevant articles for your search:NASDAQ:INO

最近閲覧した銘柄

COIN
ADNTUSD
Aladdin
LSE
1GIS
Wt Gilts 10y1xs
TG
BO4
Borregaard ASA
COIN
NBLLUST
Nobility
BIT
UV8CS8
UniCredit Bank
COIN
GENEEGBP
Genopets
NASDAQ
ABBGQXX
Jpmorgan Chase Bank Na P...
TSXV
RNP.WT
Royalty North Partners
COIN
CRSUSD
LSE
DS58
Morg.st.b.v 24
BIT
UC7A99
Unicredit Bank
LSE
MGZ6
BMF
DIIF32F33
DIIF32F33 - 01/2032
LSE
AX92
Pmf2024-1 60 A
BOV
PETRS301
PETRS301 Ex:27,37
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有